Download PDFPDF
Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Authors Response
    • Shane George
    • Other Contributors:
      • Kay Dhadwal, Sharif Al-Ruzzeh, Thanos Athanasiou, Marina Choudhury, Paris Tekkis, Pynee Vuddamalay, Haifa Lyster and Mohamed Amrani

    Dear Editor,

    We thank Drs Mclaren et al. for their interest in our study.

    Firstly, we chose Vancomycin as we wished to use an antistaphylococcal drug that had been studied in cardiac surgical patients. Additional rifampicin was used in an attempt to prevent resistance developing. Clearly the strategy was successful as we did not see any increase in resistant organisms during, or for the 2 years after,...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Antibiotic prophylaxis in cardiac surgery
    • Graeme MacLaren, Intensivist
    • Other Contributors:
      • Siang Fei Yeoh and Denis Spelman

    Dear Editor,

    The recent study by Dhadwal et al. (1) has a number of weaknesses which merit discussion. The study appears to have been initiated by a “perceived increase in crude infection rates” but the organisms responsible for this increase were not presented. Unless there was a high incidence of infection with resistant organisms such as methicillin- resistant Staphylococcus aureus (MRSA) prior to study comme...

    Show More
    Conflict of Interest:
    None declared.